- Learn how to align clinical development strategies with licensing milestones to accelerate commercialization in women’s health.
- Explore what pharma and late stage investors look for in licensing-ready assets, from early efficacy signals to regulatory preparedness.
- Understand how to navigate clinical, legal, and market access challenges unique to women’s health to build a compelling licensing case.
Speaker(s):
Oliver Bates
Chief Executive Officer
Viramal
Time:
4.30
Agenda Track No.:
Track 5
Session Type:
General Session (Presentation)